◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

TEVOGEN BIO HOLDINGS INC.

CIK: 1860871 SIC: 2836
-
Revenue
$-31.04M
Net Income
-
Gross Margin
-
Op. Margin
$-23.00M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 17 of 13 quarterly reports available
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Operating Expenses $5.73M $5.44M $10.36M $9.36M $6.09M $8.60M $29.52M $2.01M $605.97K $526.58K $493.91K $212.79K $198.83K $258.58K $282.88K - $115.00
Research & Development $3.11M $2.70M $3.20M $2.84M $3.26M $4.12M $20.81M $908.05K - - - - - - - - -
Operating Income $-5.73M $-5.44M $-10.36M $-9.36M $-6.09M $-8.60M $-29.52M $-2.01M - - - - - - - - -
Interest Expense - - $24.57K $15.80K $12.46K - $155.79K $-632.80K - - - - - - - - -
Other Income/Expense - - - - - - - $-181.42K $327.23K $331.52K $1.73M $2.83M $1.81M $465.58K $256.89K - -
Net Income $-5.73M $-5.50M $-10.37M $-9.44M $-5.88M $-9.66M $11.26M $-828.92K $-278.75K $-195.06K $1.24M $2.61M $1.61M $207.00K $-25.99K - $-115.00
Basic EPS -0.03 -0.03 -0.07 -0.06 -0.03 -0.04 0.08 -0.14 nan nan nan nan nan nan nan - 0.00
Diluted EPS -0.03 -0.03 -0.07 -0.06 -0.03 -0.04 -0.26 -0.14 nan nan nan nan nan nan nan - nan
Basic Shares Outstanding 196.0M 184.3M 161.4M -13.3M 170.2M 154.2M 137.3M - - - - - - - - - 10.3M
Diluted Shares Outstanding 196.0M 184.3M 161.4M -13.3M 170.2M 154.2M 142.4M - - - - - - - - - 10.3M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Cash & Cash Equivalents $1.04M $685.23K $1.97M $1.28M $2.33M $1.14M $1.32M $8.84K $347.55K $556.01K $52.28K $129.19K $143.05K $185.65K $231.55K $344.58K -
Other Current Assets $925.82K $1.22M $944.06K $919.09K $1.04M $1.15M $923.20K $2.50K $51.93K $143.32K $44.78K $145.17K $275.43K $409.11K $502.61K $446.61K -
Total Current Assets $2.12M $2.06M $3.08M $2.36M $3.53M $2.45M $2.40M $355.84K $399.47K $699.33K $97.06K $274.36K $418.47K $594.75K $734.16K $791.19K -
Property Plant & Equipment $163.93K $164.45K $255.89K $296.44K $336.99K $377.55K $418.10K $458.65K - - - - - - - - -
Other Non-current Assets $565.88K $565.88K $575.84K $575.84K $133.28K $133.28K $133.28K $271.14K - - - - - - - - -
Total Assets $4.49M $4.27M $4.07M $3.46M $4.29M $3.31M $3.36M $17.04M $26.41M $26.38M $25.47M $357.14M $354.54M $352.98M $352.83M $352.85M $166.79K
Accounts Payable $3.31M $4.24M $4.66M $5.20M $5.84M $6.67M $5.21M $3.42M - - - - - - - - -
Accrued Liabilities $1.20M $1.61M $1.98M $1.71M $1.41M $1.78M $1.56M $1.10M - - - - - - - - -
Other Current Liabilities - - - - - - - $230.00K $200.00K $200.00K - $140.00K - - - - -
Total Current Liabilities $6.74M $8.08M $8.72M $9.04M $10.42M $10.61M $8.94M $3.00M $1.83M $1.52M $667.07K $350.45K $281.78K $259.23K $179.00K $59.38K $153.20K
Total Liabilities $12.32M $13.75M $11.79M $10.14M $10.48M $10.94M $9.17M $17.73M $16.56M $16.25M $15.43M $15.06M $15.08M $15.13M $15.18M $15.18M $153.20K
Common Stock $19.74K $19.37K $18.39K $17.80K $17.08K $16.88K $16.46K $12.00K - - - - - - - - -
Retained Earnings $-134.98M $-129.26M $-123.75M $-113.39M $-103.94M $-98.06M $-88.39M $-17.38M $-16.16M $-15.55M $-15.33M $-14.78M $-14.66M $-14.05M $-14.26M $-14.23M $-11.41K
Total Stockholders Equity $-7.82M $-9.48M $-7.72M $-6.67M $-6.19M $-7.63M $-5.80M $-17.38M $-16.16M $-15.55M $-15.33M $-14.78M $-14.66M $-14.05M $-14.25M $-14.23M $13.59K
Total Liabilities & Equity $4.49M $4.27M $4.07M $3.46M $4.29M $3.31M $3.36M $17.04M $26.41M $26.38M $25.47M $357.14M $354.54M $352.98M $352.83M $352.85M $166.79K
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Net Income $-5.73M $-5.50M $-10.37M $-9.44M $-5.88M $1.60M $11.26M $-828.92K $761.60K $-195.06K $1.24M $2.61M $1.79M $207.00K $-25.99K - $-11.41K
Stock-based Compensation $13.78M $10.53M $7.29M $6.96M $33.80M $30.48M $26.33M - - - - - - - - - -
Operating Cash Flow $-10.15M $-6.50M $-3.31M $-3.05M $-8.95M $-5.15M $-2.16M $-693.71K $-682.64K $-474.18K $-76.90K $-13.86K $-201.53K $-158.94K $-113.03K - -
Capital Expenditure - - - - - - - - - - - - - - - - -
Investing Cash Flow - - - - - - - $9.65M $333.27M $333.27M $333.27M - - - - - -
Stock Repurchased - - - - - - - $9.71M $333.27M $333.27M - - - - - - -
Financing Cash Flow $9.90M $5.90M $4.00M $2.00M $10.23M $5.23M $2.43M $-9.29M $-332.37M $-332.37M $-333.27M - - - - - -
Net Change in Cash $-245.90K $-597.77K $691.94K $-1.05M $1.28M $82.99K - $-1.55M - - - - - - - - -
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $5.73M - $21.53M -
Research & Development $3.11M - $9.01M -
Operating Income $-5.73M - $-21.53M -
Net Income $-5.73M $-9.66M $-21.60M -
Basic EPS -0.03 - -0.12 -
Diluted EPS -0.03 - -0.12 -
Basic Shares Outstanding $196.03M - $187.09M -
Diluted Shares Outstanding $196.03M - $187.09M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $1.04M $1.28M
Other Current Assets $925.82K $919.09K
Total Current Assets $2.12M $2.36M
Property Plant & Equipment $163.93K $296.44K
Other Non-current Assets $565.88K $575.84K
Total Assets $4.49M $3.46M
Accounts Payable $3.31M $5.20M
Accrued Liabilities $1.20M $1.71M
Total Current Liabilities $6.74M $9.04M
Total Liabilities $12.32M $10.14M
Common Stock $19.74K $17.80K
Retained Earnings $-134.98M $-113.39M
Total Stockholders Equity $-7.82M $-6.67M
Total Liabilities & Equity $4.49M $3.46M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-5.73M $-9.66M $-21.60M -
Stock-based Compensation - - $13.78M -
Operating Cash Flow - - $-10.15M -
Investing Cash Flow - - - -
Financing Cash Flow - - $9.90M -
Net Change in Cash - - $-245.90K -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...